FDA Approves Generic Zomig and Zomig-ZMT Tablets

The U.S. Food and Drug Administration has approved the first generic versions of Zomig and Zomig-ZMT (orally disintegrating tablets). Zomig is in the class of drugs called triptans, and is indicated for the acute treatment of migraine with or without aura in adults. The generic Zolmitriptan tablets will be available in 2.5 mg and 5 mg strengths. Apotex Corp., Glenmark Generics and Mylan Pharmaceuticals, Inc. have said their distributions will begin immediately. Apotex and Glenmark will also produce Zolmitriptan Orally Disintegrating Tablets in 2.5 mg and 5 mg strengths.   www.drugs.com